Abstract
Allograft inflammatory factor-1 (AIF-1) is a 17-kDa IFN- γ inducible Ca2+-binding EF-hand protein involved in immune dysfunction and smooth muscle cell activation. AIF-1 was solubly expressed in E. coli and purified. Crystals of AIF-1 were grown at 291 K using PEG-8000 as precipitant. Diffraction by the AIF-1 crystal extends to 3.3 Å resolution, and the crystal belongs to the space group P43 with unit cell parameters a=b=73.4, c=49.1 Å .
Keywords: Allograft inflammatory factor 1, prokaryotic expression, crystallization
Protein & Peptide Letters
Title: Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1
Volume: 13 Issue: 8
Author(s): Shentao Li, Xiaoping Liao, Zhangliu Chen and Mark Bartlam
Affiliation:
Keywords: Allograft inflammatory factor 1, prokaryotic expression, crystallization
Abstract: Allograft inflammatory factor-1 (AIF-1) is a 17-kDa IFN- γ inducible Ca2+-binding EF-hand protein involved in immune dysfunction and smooth muscle cell activation. AIF-1 was solubly expressed in E. coli and purified. Crystals of AIF-1 were grown at 291 K using PEG-8000 as precipitant. Diffraction by the AIF-1 crystal extends to 3.3 Å resolution, and the crystal belongs to the space group P43 with unit cell parameters a=b=73.4, c=49.1 Å .
Export Options
About this article
Cite this article as:
Li Shentao, Liao Xiaoping, Chen Zhangliu and Bartlam Mark, Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1, Protein & Peptide Letters 2006; 13 (8) . https://dx.doi.org/10.2174/092986606777841208
DOI https://dx.doi.org/10.2174/092986606777841208 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Isatin Derivatives and Their Antiviral Properties Against Arboviruses: A Review
Mini-Reviews in Medicinal Chemistry Plant Phenolic Compounds as Potential Lead Compounds in Functional Foods for Antiviral Drug Discovery
Current Organic Chemistry Optimization of Spotting Buffer for Polystyrene Based ELISA Arrays
Current Analytical Chemistry Meet Our Editorial Board Member
Reviews on Recent Clinical Trials Virulence on the Fly: Drosophila melanogaster as a Model Genetic Organism to Decipher Host-Pathogen Interactions
Current Drug Targets What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies?
Current Rheumatology Reviews Primary Sjögren’s Syndrome Presenting with Rapidly Progressive Dementia: A Case Report
Current Alzheimer Research Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury
Current Neurovascular Research Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Ca<sup>2+</sup>]<sub>i</sub>, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity
Current HIV Research Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS
Current Topics in Medicinal Chemistry PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Quantitative and Mechanistic Studies of Aβ Immunotherapy
CNS & Neurological Disorders - Drug Targets Alcohol Abuse and HIV Infection: Role of DRD2
Current HIV Research Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Antiviral Treatment of Chikungunya Virus Infection
Infectious Disorders - Drug Targets Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience HSV Amplicons: Neuro Applications
Current Gene Therapy